Noa Therapeutics Patents

Patent portfolio assigned to Noa Therapeutics (verified via public assignee records). Toronto preclinical biotech (founded 2022; JLABS Toronto resident). Computer-assisted drug discovery for multimodal therapeutics targeting inflammatory/immune skin diseases (lead in atopic dermatitis). Company filed provisional patent(s) on its small molecules (per CDL/Medsider); count not visible. Partner/collaborator: Johns Hopkins Dept. of Dermatology (NEA grant to study lead compound). No direct commercial competitors confidently sourced.